ArticleJournal of fluorescence2026
Green-Synthesized Chaenomeles speciosa-Derived Carbon Quantum Dots with Blue Fluorescence and Selective Pro-Apoptotic Effects in Cancer Cells.
Article in Journal of fluorescence, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
5 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Carbon nanodots were synthesized from Chaenomeles speciosa flowers and comprehensively characterized. UV-Vis analysis revealed a broad absorption band from 200 to 400 nm, attributed to π→π* (200-250 nm) and n→π* (250-350 nm) transitions, while fluorescence under 365 nm excitation showed bright blue emission. HRTEM images indicated spherical nanoparticles forming clustered aggregates, with lattice fringes exhibiting interplanar spacings of 0.091-0.093 nm, confirming a partially graphitic structure. XRD analysis showed a broad amorphous baseline in the 10-40° 2θ range, indicating low crystallinity. FTIR and XPS analyses identified abundant surface -OH, C = O, and C-O groups, with elemental composition of C 68.28%, O 23.03%, N 6.70%, S 0.40%, and Si 1.59%, resulting in a C/O ratio of 2.97. Chaenomeles speciosa quantum dots (CS-CQDs) exhibited dose-dependent cytotoxicity in MDA-MB-231 cells (viability: 70% at 2.5 mg/mL, 60% at 5 mg/mL) and HeLa cells (approximately 50% at 2.5-5 mg/mL), with minimal effects on hTERT-HME1 cells (viability greater than 85% at 0.6 mg/mL). Apoptosis increased from 25% to 55% in MDA-MB-231, from 24% to 65% in HeLa, and from 5.9% to 25% in HME1, with negligible necrosis. Gene expression analyses showed NF-κB upregulation (3-fold in MDA-MB-231; 6-fold in HeLa), BAX and BCL-2 upregulation in HeLa (approximately 2.5-fold), and downregulation of HIF1A, IL-6, MMP2, and MMP9. Wound healing assays indicated reduced migration in MDA-MB-231 (44% to 21%), increased migration in HeLa (18.7% to 30%), and minimal change in HME1 (73.5% to 71.5%). These results demonstrate that CS-CQDs possess favorable optical and structural properties and selectively induce apoptosis in cancer cells, with minimal impact on non-cancerous cells, highlighting their potential as targeted anticancer nanomaterials.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.